http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101048377-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101048377-B1 |
| titleOfInvention | 2,4-bis (trifluoroethoxy) pyridine compound and medicine containing the same. |
| abstract | The present invention is formula (1)n n n [Tue 1]n n n n n n n n (Wherein X 1 represents a fluorine atom or a hydrogen atom)n n n The present invention relates to a 2,4-bis (trifluoroethoxy) pyridine compound or a salt thereof and a medicament containing the same as an active ingredient.n n n It exhibits metabolic resistance to human hepatic microsomes, shows good oral absorption and also has good ACAT inhibitory activity. |
| priorityDate | 2003-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.